Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome

Autor: Kuehne, A., Bouwknegt, M., Havelaar, A., Gilsdorf, A., Hoyer, Peter Friedrich, Stark, K., Werber, D., Amon, Oliver, Büscher (R.), Rainer, Hampel, Tobias, Fehrenbach, Henry, Habbig, Sandra, Pohl, Martin, Häffner, Karsten, Hoppe, Bernd, Klaus, Günter, Konrad, Martin, Latta, Kay, Leichter, Heinz, Loos, Sebastian, Montoya, Carmen, Müller, Dominik, Galiano, Matthias, Muschiol, Evelin, Pape, Lars, Staude, Hagen, Wühl, Elke, Henn, Michael, Pohl, Michael, Wygoda, Simone
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Pediatrics
Epidemiology
enterohaemorrhagic Escherichia coli
animal diseases
Medizin
Non o157
0302 clinical medicine
fluids and secretions
Germany
030212 general & internal medicine
Burden of illness
Child
Escherichia coli Infections
Aged
80 and over

education.field_of_study
Shiga-Toxigenic Escherichia coli
Incidence (epidemiology)
Middle Aged
Original Papers
Bloody
Monte Carlo method
Infectious Diseases
Child
Preschool

Disease Notification
Adult
medicine.medical_specialty
Adolescent
030106 microbiology
Population
Biology
Escherichia coli O157
Microbiology
03 medical and health sciences
Young Adult
medicine
Humans
education
Shiga toxin-producing Escherichia coli
Aged
Infant
Newborn

Infant
biochemical phenomena
metabolism
and nutrition

bacterial infections and mycoses
Hemolytic-Uremic Syndrome
Etiology
incidence
bacteria
Haemolytic-uraemic syndrome
Zdroj: Epidemiol Infect
Epidemiology and Infection, 144(15), 3305. Cambridge University Press
ISSN: 0950-2688
Popis: SUMMARYShiga toxin-producingEscherichia coli(STEC) is an important cause of gastroenteritis (GE) and haemolytic uraemic syndrome (HUS). Incidence of STEC illness is largely underestimated in notification data, particularly of serogroups other than O157 (‘non-O157’). Using HUS national notification data (2008–2012, excluding 2011), we modelled true annual incidence of STEC illness in Germany separately for O157 and non-O157 STEC, taking into account the groups’ different probabilities of causing bloody diarrhoea and HUS, and the resulting difference in their under-ascertainment. Uncertainty of input parameters was evaluated by stochastic Monte Carlo simulations. Median annual incidence (per 100 000 population) of STEC-associated HUS and STEC-GE was estimated at 0·11 [95% credible interval (CrI) 0·08-0·20], and 35 (95% CrI 12-145), respectively. German notification data underestimated STEC-associated HUS and STEC-GE incidences by factors of 1·8 and 32·3, respectively. Non-O157 STEC accounted for 81% of all STEC-GE, 51% of all bloody STEC-GE and 32% of all STEC-associated HUS cases. Non-O157 serogroups dominate incidence of STEC-GE and contribute significantly to STEC-associated HUS in Germany. This might apply to many other countries considering European surveillance data on HUS. Non-O157 STEC should be considered in parallel with STEC O157 when searching aetiology in patients with GE or HUS, and accounted for in modern surveillance systems.
Databáze: OpenAIRE